Cover Image
市場調查報告書

更年期發熱症治療市場 (各產品類型 (荷爾蒙藥、非荷爾蒙藥) ) - 全球產業分析、規模、構成比、成長率、趨勢及預測:2015-2023年

Menopausal Hot Flashes Market: (By Product Type: Hormonal (Estrogen, Progesterone, and Combination), Non-Hormonal, (Brisdelle, and Other Anti-Depressants) Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

出版商 Transparency Market Research 商品編碼 350565
出版日期 內容資訊 英文 86 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
更年期發熱症治療市場 (各產品類型 (荷爾蒙藥、非荷爾蒙藥) ) - 全球產業分析、規模、構成比、成長率、趨勢及預測:2015-2023年 Menopausal Hot Flashes Market: (By Product Type: Hormonal (Estrogen, Progesterone, and Combination), Non-Hormonal, (Brisdelle, and Other Anti-Depressants) Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日期: 2015年12月31日 內容資訊: 英文 86 Pages
簡介

本報告以更年期發熱症治療 (Menopausal Hot Flash) 治療的全球市場為焦點,提供2015-2023年的期間的交易規模變化依各產品類型 (產品類型 (荷爾蒙藥:雌激素、孕酮、複合藥)、非荷爾蒙藥:Brisdelle、其他抗憂鬱藥) ) 及地區分類的預測,產業結構,供需趨勢,開發新藥,推動、阻礙因素,機會,競爭環境等分析資訊和主要加入企業簡介彙整。

第1章 序

  • 報告說明
  • 市場區隔
  • 調查方法

第2章 摘要整理

  • 更年期發熱症治療的全球市場簡述
  • 更年期發熱症治療的全球市場構成比 - 各地區:2014年及2023年 (金額比)
  • 更年期發熱症治療的全球市場收益 - 各地區:2014年 (單位:100萬美元)

第3章 更年期發熱症治療的市場 - 產業分析

  • 簡介
  • 市場動態
    • 推動要素
      • 全球常見的更年期血管舒縮症狀
      • 新的治療選擇的認證
      • 高漲的女性的健康意識
    • 阻礙因素
      • 荷爾蒙補充療法 (HRT) 的乳癌風險
      • 增大的替代治療需求
    • 市場機會
      • 新興市場帶來持續的成長機會
  • 市場向心力分析 - 各地區:2014年
  • 競爭環境、市場佔有率分析 - 主要加入企業:2014年 (金額比)

第4章 市場區隔

  • 簡介
  • 更年期發熱症治療的全球市場收益 - 各療法:2013-2023年 (單位:100萬美元)
  • 更年期發熱症治療的全球市場收益 - 各產品:2013-2023年 (單位:100萬美元)
  • 荷爾蒙治療的全球市場收益 - 各產品:2013-2023年 (單位:100萬美元)
    • 雌激素
      • Premarin
      • Vivelle-Dot
    • purogesutin
      • Prometrium
    • 複合治療
      • Duavee
      • Prempro
  • 非荷爾蒙治療的全球市場收益:2013-2023年 (單位:100萬美元)
    • Brisdelle

第5章 開發平台分析

  • 第一階段、第二階段的藥物 - 表格形式的彙整
  • 更年期發熱症治療第三階段藥物市場預測收益:2017-2023年 (單位:100萬美元)

第6章 市場區隔 - 各地區

  • 更年期發熱症治療的全球市場收益 - 各地區:2013-2023年 (單位:100萬美元)
    • 北美的更年期發熱症治療收益 - 各國
    • 歐洲的更年期發熱症治療收益 - 各國
    • 亞太地區的更年期發熱症治療收益 - 各國
    • 其他地區的更年期發熱症治療收益 - 各國

第7章 建議

第8章 企業簡介

  • Allergan plc
  • Bayer AG
  • 久光製藥株式會社
  • Merck & Co., Inc.
  • Npvartis International AG
  • Novo Nordisk
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
目錄

This report on the menopausal hot flashes market studies the current and future prospects of the treatment across the globe. Hot flashes are common symptoms experience by women in menopause transition. Hot flashes are defined as ephemeral, recurring periods of heat sensation and redness, often associated with sweat and are experienced by about 75% of women in the U.S and Europe at some point before or during the menopause period. These tend to decrease in severity and frequency over a few months to a few years, but sometimes persist into old age.

The menopausal hot flashes market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global menopausal hot flashes drugs market with respect to the segments based on the type of therapy, and their geographic analysis. A detailed qualitative analysis of driving and restraining factors for the market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global menopausal hot flashes market.

Based on therapy type, the menopausal hot flashes market has been segmented into two major categories: hormonal and non-hormonal treatment. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the global menopausal drugs market has been categorized into four major regions and the key countries in the respective region: North America (U.S., Canada), Europe (U.K., Germany, France, Rest of Europe), Asia Pacific (Japan, Australia, India, China, Rest of Asia Pacific), and Rest of the World (Latin America, Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global menopausal hot flashes market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Allergan plc, Bayer AG, Hisamitsu Pharmaceutical Co., Inc., Merck & Co. Inc., Novartis International AG, Novo Nordisk, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.

The global menopausal hot flashes market is segmented as follows:

Global Menopausal Hot Flashes Market, by Therapy Type

  • Hormonal
    • Estrogen
      • Premarin
      • Vivelle-Dot
    • Progestin
      • Prometrium
    • Combination Therapy
      • Duavee
      • Prempro
    • Non-Hormonal
      • Brisdelle

Global Menopausal Hot Flashes Market, Pipeline Analysis

  • Phase I and II Drugs
  • Phase III Drugs

Global Menopausal Hot Flashes Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • Australia
    • Japan
    • India
    • China
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East and Africa

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

  • 2.1. Menopausal Hot Flashes Market Snapshot
  • 2.2. Global Menopausal Hot Flashes Market Share, by Geography, 2014 & 2023 (Value %)
  • 2.3. Global Menopausal Hot Flashes Market Revenue, by Geography, 2014 (US$ Mn)
  • 2.4. Global Menopausal Hot Flashes Market, by Therapy, 2014 (US$ Mn)

3. Menopausal Hot Flashes Market - Industry Analysis

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Rise in menopausal vasomotor symptoms across the globe
      • 3.2.1.2. Approval of new treatment options
      • 3.2.1.3. Growing women health awareness
    • 3.2.2. Restraints
      • 3.2.2.1. Risk of breast cancer with HRT treatment
      • 3.2.2.2. Growing demand for alternative therapies
    • 3.2.3. Opportunities
      • 3.2.3.1. Emerging economies to offer sustained growth opportunities
  • 3.3. Market Attractiveness Analysis, by Geography, 2014
  • 3.4. Competitive Landscape, Market Share Analysis, by Key Players, 2014 (Value %)

4. Market Segmentation - By Therapy

  • 4.1. Introduction
  • 4.2. Global Menopausal Hot Flashes Revenue, by Therapy, 2013-2023 (US$ Mn)
  • 4.3. Global Menopausal Hot Flashes Market Revenue, by Product, 2013-2023, (US$ Mn)
  • 4.4. Global Hormonal Therapy Market Revenue, by Product, 2013-2023, (US$ Mn)
    • 4.4.1. Global Estrogen Market Revenue, 2013-2023, (US$ Mn)
      • 4.4.1.1. Global Premarin Flashes Market Revenue, 2013-2023, (US$ Mn)
      • 4.4.1.2. Global Vivelle-Dot Market Revenue, 2013-2023, (US$ Mn)
    • 4.4.2. Global Progestin Market Revenue, 2013-2023, (US$ Mn)
      • 4.4.2.1. Global Prometrium Market Revenue, 2013-2023, (US$ Mn)
    • 4.4.3. Global Combination Therapy Market Revenue, 2013-2023, (US$ Mn)
      • 4.4.3.1. Global Duavee Market Revenue, 2013-2023, (US$ Mn)
      • 4.4.3.2. Global Prempro Market Revenue, 2013-2023, (US$ Mn)
  • 4.5. Global Non-hormonal Market Revenue, 2013-2023, (US$ Mn)
    • 4.5.1. Global Brisdelle Market Revenue, 2013-2023, (US$ Mn)

5. Pipeline Analysis

  • 5.1. Phase I and II Drugs, Tabular Representation
  • 5.2. Menopausal Hot Flashes Phase III Drugs Market Revenue, 2017 - 2023 (USD Million)

6. Market Segmentation - By Geography

  • 6.1. Global Menopausal Hot Flashes Market Revenue, by Geography, 2013-2023
    • 6.1.1. North America Menopausal Hot Flashes Market Revenue, by Country, 2013-2023 (US$ Mn)
    • 6.1.2. Europe Menopausal Hot Flashes Market Revenue, by Country, 2013-2023 (US$ Mn)
    • 6.1.3. Asia Pacific Menopausal Hot Flashes Market Revenue, by Country, 2013-2023 (US$ Mn)
    • 6.1.4. Rest of the World Menopausal Hot Flashes Market Revenue, by Country, 2013-2023 (US$ Mn)

7. Recommendations

8. Company Profiles

  • 8.1. Allergan plc
  • 8.2. Bayer AG
  • 8.3. Hisamitsu Pharmaceutical Co., Inc.
  • 8.4. Merck & Co., Inc.
  • 8.5. Npvartis International AG
  • 8.6. Novo Nordisk
  • 8.7. Pfizer, Inc.
  • 8.8. Teva Pharmaceutical Industries Ltd.
Back to Top